Pfizer Drug Treating Fatal Weight Loss in Cancer Patients Found Effective - Investopedia

Pfizer announced positive results for ponsegromab in a Phase 2 trial for treating cancer cachexia, with plans for late-stage trials next year. The drug showed improvements in body weight, muscle mass, quality of life, and physical function.